Abstract

Previous studies have indicated that at least part of the selection of proteins for degradation takes place at a binding site on ubiquitin-protein ligase, to which the protein substrate is bound prior to ligation to ubiquitin. It was also shown that proteins with free NH2-terminal alpha-NH2 groups bind better to this site than proteins with blocked NH2 termini (Hershko, A., Heller, H., Eytan, E., and Reiss, Y. (1986) J. Biol. Chem. 261, 11992-11999). In the present study, we used simple derivatives of amino acids, such as methyl esters, hydroxamates, or dipeptides, to examine the question of whether the protein binding site of the ligase is able to distinguish between different NH2-terminal residues of proteins. Based on specific patterns of inhibition of the binding to ligase by these derivatives, three types of protein substrates could be distinguished. Type I substrates are proteins that have a basic NH2-terminal residue (such as ribonuclease and lysozyme); these are specifically inhibited by derivatives of the 3 basic amino acids (His, Arg, and Lys) with respect to degradation, ligation to ubiquitin, and binding to ligase. Type II substrates (such as beta-lactoglobulin or pepsinogen, that have a Leu residue at the NH2 terminus) are not affected by the above compounds, but are specifically inhibited by derivatives of bulky hydrophobic amino acids (Leu, Trp, Phe, and Tyr). In these cases, the amino acid derivatives apparently act as specific inhibitors of the binding of the NH2-terminal residue of proteins, as indicated by the following observations: (a) derivatives in which the alpha-NH2 group is blocked were inactive and (b) in dipeptides, the inhibitory amino acid residue had to be at the NH2-terminal position. An additional class (Type III) of substrates comprises proteins that have neither basic nor bulky hydrophobic NH2-terminal amino acid residues; the binding of these proteins is not inhibited by homologous amino acid derivatives that have NH2-terminal residues similar to that of the protein. It is concluded that Type I and Type II proteins bind to distinct and separate subsites of the ligase, specific for basic or bulky hydrophobic NH2-terminal residues, respectively. On the other hand, Type III proteins apparently predominantly interact with the ligase at regions of the protein molecule other than the NH2-terminal residue.

Highlights

  • From the Unit of Biochemistry, Faculty of Medicine and Rappaport Family Institute, Technion-Israel Institute of Technology, Haifa, 31096 Israel

  • We used simple derivatives of amino acids, such as methyl esters, hydroxamates, or dipeptides, toexaminethe question of whether the protein binding siotfe the ligase is able distinguish between different NHderminal residues mechanisms that determine the selectivity of the ubiquitinprotein ligase system are thusof obvious interest

  • Other investigators have subsethe bindingto ligase by these derivatives, three types quently observed that thenature of the NH,terminal residue of protein substrates could be distinguished

Read more

Summary

USE OF AMINO ACID DERIVATIVES T O CHARACTERIZE SPECIFIC BINDING SITES*

Type I1 substrates (such as &lactoglobulin or pepsinogen, that have a Leu residue at the NH2terminus) are not affected by the above compounds, but are inhibited by derivatives of bulky hydrophobic amino acids (Leu, Trp, Phe, and Tyr) In these cases, the amino acid derivatives apparently act as specific inhibitors of the binding of the NHz-terminal residue of proteins, as indicated by the following observations:. Assay of Protein Breakdown-Unless otherwise specified, reaction mixtures contained in a volume of 50 pl: 50 mM Tris-HC1 (pH 7.6), 5 mM MgCI, 3 mM DTT, 4 mM ATP, 3 pg of ubiquitin, approximately 200 pgof protein of Fraction I1 from reticulocytes, 0.05-2 pg (2-10 X IO4cpm) of '251-labeledprotein substrate, and tested compounds as specifiedin the legends. The samples were separated on an 8% SDS-polyacrylamide gel, dried, and autoradiographed

RESULTS
Effect of dipeptides on the degradation of differentproteins
Ser Met
Thr None
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.